There Are Now Psychedelics Companies Listed In The U.S.

Just two years ago, the psychedelics sector was a small research space reserved for academics and extremely forward-thinking investors.
Since early 2020, the industry for medicinal psychedelic drugs received an extraordinary injection of capital, launching several companies in major exchanges like the NYSE and the Nasdaq, some of which now have valuations of over $1 billion.

Psychedelics Companies Listed On The Nasdaq And NYSE
Atai Life Sciences ( $ATAI Life Sciences (ATAI.US)$ )
Compass Pathways ( $COMPASS Pathways (CMPS.US)$ )
MindMed ( $Mind Medicine (MNMD.US)$ )
Field Trip Health, Inc. ( $Field Trip Health (FTRP.US)$ )
Seelos Therapeutics ( $Seelos Therapeutics (SEEL.US)$
Enveric Biosciences ( $Enveric Biosciences (ENVB.US)$ )
Pasithea Therapeutics Corp. ( $Pasithea Therapeutics (KTTA.US)$ )
GH Research ( $Coherus BioSciences (CHRS.US)$ )
Cybin Corp ( $Cybin (CYBN.US)$ )